Nab-paclitaxel + gimeracil/oteracil/tegafur in Japanese patients with HER2-negative metastatic breast cancer
Latest Information Update: 08 Feb 2014
At a glance
- Drugs Gimeracil/oteracil/tegafur (Primary) ; Paclitaxel (Primary)
- Indications Advanced breast cancer
- Focus Adverse reactions
- 08 Feb 2014 New trial record
- 14 Dec 2013 Results presented at the 36th Annual San Antonio Breast Cancer Symposium.